Literature DB >> 1722865

Renal magnesium wasting associated with therapeutic agents.

G M Shah1, M A Kirschenbaum.   

Abstract

Renal magnesium wasting is an important cause of hypomagnesemia observed in hospitalized patients. The purpose of this review is to present an index case of symptomatic hypomagnesemia associated with renal magnesium wasting during capreomycin therapy, and to survey the available literature regarding the various therapeutic agents associated with the causation of this syndrome. Finally, we have considered the pathophysiologic mechanisms that may contribute to the development of the multiple electrolyte abnormalities observed in these patients, and have outlined the current strategies to treat this syndrome.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1722865

Source DB:  PubMed          Journal:  Miner Electrolyte Metab        ISSN: 0378-0392


  12 in total

1.  Clinical significance of fractional magnesium excretion (FEMg) as a predictor of interstitial nephropathy and its correlation with conventional parameters.

Authors:  Chie Noiri; Taisuke Shimizu; Kaori Takayanagi; Yosuke Tayama; Takatsugu Iwashita; Shimpei Okazaki; Minoru Hatano; Osamu Matsumura; Hitoshi Kato; Akihiko Matsuda; Tetsuya Mitarai; Hajime Hasegawa
Journal:  Clin Exp Nephrol       Date:  2015-02-28       Impact factor: 2.801

Review 2.  Drug-induced hypomagnesaemia : scope and management.

Authors:  Jacob Atsmon; Eran Dolev
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

3.  Renal adaptation to gentamicin-induced mineral loss.

Authors:  Chien-Te Lee; Hung Chun Chen; Hwee-Yeong Ng; Li-Wen Lai; Yeong-Hau H Lien
Journal:  Am J Nephrol       Date:  2012-02-25       Impact factor: 3.754

Review 4.  A benefit-risk assessment of the use of proton pump inhibitors in the elderly.

Authors:  Gwen M C Masclee; Miriam C J M Sturkenboom; Ernst J Kuipers
Journal:  Drugs Aging       Date:  2014-04       Impact factor: 3.923

5.  On admission hypomagnesemia in critically ill children: Risk factors and outcome.

Authors:  Anwarul Haque; Ali Faisal Saleem
Journal:  Indian J Pediatr       Date:  2009-12       Impact factor: 1.967

6.  Proton pump inhibitors and symptomatic hypomagnesemic hypoparathyroidism.

Authors:  P Fatuzzo; G Portale; V Scollo; L Zanoli; Antonio Granata
Journal:  J Nephrol       Date:  2016-05-20       Impact factor: 3.902

Review 7.  Associations Between Serum Magnesium Concentrations and Polycystic Ovary Syndrome Status: a Systematic Review and Meta-analysis.

Authors:  Maedeh Babapour; Hamed Mohammadi; Maryam Kazemi; Amir Hadi; Mahsa Rezazadegan; Gholamreza Askari
Journal:  Biol Trace Elem Res       Date:  2020-08-18       Impact factor: 3.738

8.  Two unusual cases of severe recalcitrant hypocalcemia due to aminoglycoside-induced hypomagnesemia.

Authors:  Tarun Varma; Ashish Saini; Roopal Panchani; Nitin R Gupta
Journal:  Indian J Endocrinol Metab       Date:  2013-10

9.  Cardiac Dysrhythmias and Neurological Dysregulation: Manifestations of Profound Hypomagnesemia.

Authors:  Sagger Mawri; Edward Gildeh; Namita Joseph; Bobak Rabbani; Bryan Zweig
Journal:  Case Rep Cardiol       Date:  2017-06-05

Review 10.  The role of magnesium sulfate in the intensive care unit.

Authors:  Yunes Panahi; Mojtaba Mojtahedzadeh; Atabak Najafi; Mohammad Reza Ghaini; Mohammad Abdollahi; Mohammad Sharifzadeh; Arezoo Ahmadi; Seyyed Mahdi Rajaee; Amirhossein Sahebkar
Journal:  EXCLI J       Date:  2017-04-05       Impact factor: 4.068

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.